Ind-Swift Laboratories Limited has scheduled a meeting of its Board of Directors for Friday, July 10, 2026. The primary agenda for this meeting is to consider and approve a proposal for raising funds through the issuance of one or more financial instruments.
The fundraising may include equity shares and/or convertible securities through various potential methods: Preferential Issue, Rights Issue, Qualified Institutions Placement (QIP), or any other mode that the board deems appropriate. The board will also consider and determine the pricing and other modalities related to the fundraising.
Additionally, the company confirms that the trading window for dealing in the company's securities has been closed since June 26, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's internal code of conduct. This closure was implemented due to the pending declaration of the company's unaudited standalone and consolidated financial results.
The trading window will remain closed until 48 hours after the conclusion of the board meeting scheduled for July 10, 2026. This disclosure is made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The communication was signed by Pardeep Verma, VP-Corporate Affairs and Company Secretary, on July 07, 2026 at 19:10:11 IST.